|
1
|
Chew DS, Black-Maier E, Loring Z,
Noseworthy PA, Packer DL, Exner DV, Mark DB and Piccini JP:
Diagnosis-to-Ablation time and recurrence of atrial fibrillation
following catheter ablation: A systematic review and meta-analysis
of observational studies. Circ Arrhythm Electrophysiol.
13(e008128)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Virani SS, Alonso A, Aparicio HJ, Benjamin
EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng
S, Delling FN, et al: Heart disease and stroke statistics-2021
update: A report from the American Heart Association. Circulation.
143:e254–e743. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rong B, Han W, Lin M, Hao L, Zhang K, Chen
T, Sha R, Wang J, Wang R and Zhong J: Thromboembolic risk of
cessation of oral anticoagulation post catheter ablation in
patients with and without atrial fibrillation recurrence. Am J
Cardiol. 137:55–62. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kim M, Yu HT, Kim J, Kim TH, Uhm JS, Joung
B, Lee MH and Pak HN: Atrial fibrillation and the risk of ischaemic
strokes or intracranial haemorrhages: Comparisons of the catheter
ablation, medical therapy, and non-atrial fibrillation population.
Europace. 23:529–538. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Inoue K, Hirao K, Kumagai K, Kimura M,
Miyauchi Y, Tsushima E, Ohishi M, Kimura K, Yasaka M, Yamaji H, et
al: Long-term efficacy and safety of anticoagulation after atrial
fi brillation ablation: Data from the JACRE registry. J Cardiol.
77:263–270. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaplon-Cieslicka A, Budnik M, Gawalko M,
Peller M, Gorczyca I, Michalska A, Babiarz A, Bodys A, Uliński R,
Żochowski M, et al: Atrial fibrillation type and renal dysfunction
as important predictors of left atrial thrombus. Heart.
105:1310–1315. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Conen D, Rodondi N, Muller A, Beer JH,
Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, et
al: Relationships of overt and silent brain lesions with cognitive
function in patients with atrial fibrillation. J Am Coll Cardiol.
73:989–999. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang WY, Du X, Jiang C, He L, Fawzy AM,
Wang L, Liu C, Xia SJ, Chang SS, Guo XY, et al: The safety of
discontinuation of oral anticoagulation therapy after apparently
successful atrial fibrillation ablation: A report from the Chinese
Atrial Fibrillation Registry study. Europace. 22:90–99.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chang SS, Dong JZ, Ma CS, Du X, Wu JH,
Tang RB, Xia SJ, Guo XY, Yu RH, Long DY, et al: Current status and
time trends of oral anticoagulation use among Chinese Patients with
nonvalvular atrial fibrillation: The Chinese Atrial fibrillation
registry study. Stroke. 47:1803–1810. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Saglietto A, De Ponti R, Di Biase L, Matta
M, Gaita F, Romero J, De Ferrari GM and Anselmino M: Impact of
atrial fibrillation catheter ablation on mortality, stroke, and
heart failure hospitalizations: A meta-analysis. J Cardiovasc
Electrophysiol. 31:1040–1047. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mansour M, Heist EK, Agarwal R, Bunch TJ,
Karst E, Ruskin JN and Mahapatra S: Stroke and cardiovascular
events after ablation or antiarrhythmic drugs for treatment of
patients with atrial fibrillation. Am J Cardiol. 121:1192–1199.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Srivatsa UN, Danielsen B, Amsterdam EA,
Pezeshkian N, Yang Y, Nordsieck E, Fan D, Chiamvimonvat N and White
RH: CAABL-AF (California Study of Ablation for Atrial
Fibrillation): Mortality and Stroke, 2005 to 2013. Circ Arrhythm
Electrophysiol. 11(e005739)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Saliba W, Schliamser JE, Lavi I,
Barnett-Griness O, Gronich N and Rennert G: Catheter ablation of
atrial fibrillation is associated with reduced risk of stroke and
mortality: A propensity score-matched analysis. Heart Rhythm.
14:635–642. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schaeffer B, Ruden L, Salzbrunn T,
Pinnschmidt HO, Akbulak RO, Moser JM, Jularic M, Meyer C, Eickholt
C, Sultan A, et al: Incidence of intracardiac thrombus formation
prior to electrical cardioversion in respect to the mode of oral
anticoagulation. J Cardiovasc Electrophysiol. 29:537–547.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ganesan AN, Chew DP, Hartshorne T,
Selvanayagam JB, Aylward PE, Sanders P and McGavigan AD: The impact
of atrial fibrillation type on the risk of thromboembolism,
mortality, and bleeding: A systematic review and meta-analysis. Eur
Heart J. 37:1591–1602. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hindricks G, Potpara T, Dagres N, Arbelo
E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA,
Dilaveris PE, et al: 2020 ESC Guidelines for the diagnosis and
management of atrial fibrillation developed in collaboration with
the European Association for Cardio-Thoracic Surgery (EACTS): The
Task Force for the diagnosis and management of atrial fibrillation
of the European Society of Cardiology (ESC) Developed with the
special contribution of the European Heart Rhythm Association
(EHRA) of the ESC. Eur Heart J. 42:373–498. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Uzieblo-Zyczkowska B, Krzesinski P, Jurek
A, Budnik M, Gorczyca I, Kapłon-Cieślicka A, Kiliszek M, Wójcik A,
Gawałko M, Jelonek O, et al: Prevalence and risk factors of left
atrial thrombus in patients with atrial fibrillation and lower
class (IIa) recommendation to anticoagulants. Cardiovasc Diagn
Ther. 10:717–724. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Heeger CH, Rillig A, Geisler D, Wohlmuth
P, Fink T, Mathew S, Tilz RR, Reissmann B, Lemes C, Maurer T, et
al: Left atrial appendage isolation in patients not responding to
pulmonary vein isolation. Circulation. 139:712–715. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang J, Wu SL, Xue YM, Fei HW, Lin QW,
Ren SQ, Liao HT, Zhan XZ, Fang XH and Xu L: Association of CHADS(2)
and CHA(2)DS(2)-VASc scores with left atrial thrombus with
nonvalvular atrial fibrillation: A single center based
retrospective study in a cohort of 2695 Chinese Subjects. Biomed
Res Int. 2017(6839589)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nauffal V, Trinquart L, Osho A, Sundt TM,
Lubitz SA and Ellinor PT: Non-Vitamin K antagonist oral
anticoagulant vs warfarin for post cardiac surgery atrial
fibrillation. Ann Thorac Surg. 112:1392–1401. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sezenoz B, Yalcin Y, Caglayan HB, Yazgan
E, Kiziltunc E, Ünlü S, Altıparmak T, Nazlıel B and Özdemir HM:
Predictive value of supraventricular short runs for new-onset
atrial fibrillation in patients with ischemic stroke. Ann Indian
Acad Neurol. 26:902–907. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Echocardiographic predictors of stroke in
patients with atrial fibrillation: A prospective study of 1066
patients from 3 clinical trials. Arch Intern Med. 158:1316–1320.
1998.PubMed/NCBI View Article : Google Scholar
|
